/Companies

Biomx

NYSE: PHGE

Ness Ziona · Founded 2015 · Delaware corporation · 29 employees on LinkedIn · 9 known investors

Find your way into Biomx

17 people in our graph can introduce you to the Biomx team.

Sign up to see every warm intro you have to Biomx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomx team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.

Founders & leadership

JSJonathan Solomon
Jonathan SolomonChief Executive Officer
MBMerav Bassan
Merav BassanChief Development Officer
MWMarina Wolfson
Marina WolfsonChief Financial OfficerShe has spent over 15 years in finance roles, including more than 12 years as a principal financial officer at high-tech and biotechnology companies with US and Israeli public listings, and holds an MBA in Business Management.
JG
Jesse GoodmanNamed on SEC filing
AM
Alan MosesNamed on SEC filing
JL
Jonathan LeffNamed on SEC filing
GM
Gregory MerrilNamed on SEC filing
EW
Eddie WilliamsNamed on SEC filing
SB
Susan BlumNamed on SEC filing
RG
Russell GreigNamed on SEC filing
PS
Paul SekhriNamed on SEC filing
JG
Jonas GrossmanNamed on SEC filing

Investors · 9

Reported raises · per SEC filings

Form D private placements

$72.3M disclosed across 5 of 7 rounds · 2017–2026

▶$3.3MraisedJan 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse GoodmanDirector
  • Alan MosesDirector
  • Jonathan LeffDirector
  • Jonathan SolomonExecutive Officer, Director
  • Merav BassanExecutive Officer
  • Gregory MerrilDirector
  • Eddie WilliamsDirector
  • Susan BlumDirector
  • Russell GreigDirector
  • Marina WolfsonExecutive Officer
Offering amount
$3.3M
Amount sold
$3.3M
Sales commissions
$210K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$61.5MraisedApr 2024 · 34 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse GoodmanDirector
  • Assaf OronExecutive Officer
  • Russell GreigDirector
  • Edward WilliamsDirector
  • Gregory MerrilDirector
  • Marina WolfsonExecutive Officer
  • Jonathan LeffDirector
  • Jonathan SolomonExecutive Officer, Director
  • Alan MosesDirector
  • Avi GabayExecutive Officer
  • Merav BassanExecutive Officer
Offering amount
$61.5M
Amount sold
$61.5M
Sales commissions
$1.4M
Placement agents
RBC Capital Markets, LLC, Laidlaw & Company (UK) Ltd.
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2023 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell GreigDirector
  • Lynne SullivanDirector
  • Assaf OronExecutive Officer
  • Merav BassanExecutive Officer
  • Alan MosesDirector
  • Marina WolfsonExecutive Officer
  • Jonathan SolomonExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$1.5M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJan 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonas GrossmanDirector
  • Lynne SullivanDirector
  • Gbola AmusaDirector
  • Marina WolfsonExecutive Officer
  • Russell GreigDirector
  • Alan MosesDirector
  • Paul SekhriDirector
  • Merav BassanExecutive Officer
  • Jonathan Eitan SolomonExecutive Officer, Director
Offering amount
$5M
Amount sold
$3M
Minimum investment
$3M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedOct 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan Eitan SolomonExecutive Officer, Director
  • Paul SekhriDirector
  • Russell GreigDirector
  • Jonas GrossmanDirector
  • Lynne SullivanDirector
  • Sailaja PuttaguntaExecutive Officer
  • Marina WolfsonExecutive Officer
  • Merav BassanExecutive Officer
  • Alan MosesDirector
  • Gbola AmusaDirector
Offering amount
$3M
Amount sold
$3M
Minimum investment
$3M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as Biomx.

Frequently asked questions

What does Biomx do?
BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.
Who are Biomx's investors?
Biomx's investors include AMR Action Fund, Baruch Future Ventures, NSG Ventures, OrbiMed, SBI JI Innovation Advisory Ltd., Seventure Partners, 8VC, Deerfield Management Company and 1 more.
How much funding has Biomx raised?
Biomx has disclosed $72.3M raised across 5 of its 7 known rounds.
Where is Biomx headquartered?
Biomx is headquartered in Ness Ziona.